SCHEMBL25880355

SCHEMBL25880355

Cc1ccccc1-c1ccc2c3c1c1ccccc1n3c1ccc(-c3ccccc3C)c3c4ccccc4n2c31

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
KDM4E B2RXH2 3/20 0.41
BRD4 O60885 1/20 0.39
ALKBH5 Q6P6C2 1/20 0.39
FTO Q9C0B1 1/20 0.39
PABPC1 P11940 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MCL1 Q07820 3/20 0.34
BAD Q92934 2/20 0.34
NQO2 P16083 1/20 0.34
PDE10A Q9Y233 2/20 0.34
PDE2A O00408 1/20 0.34
NR3C1 P04150 1/20 0.33
PGR P06401 1/20 0.33
NTRK1 P04629 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22178720 0.77 NR3C1 (0.37) MAPTKDM4EBRD4ALKBH5FTO
SCHEMBL20857886 0.77 MAPT (0.34) MAPTKDM4EBRD4ALKBH5FTO
SCHEMBL22178500 0.76 NR3C1 (0.41) MAPTKDM4EALKBH5FTOMCL1
SCHEMBL31683716 0.74 HSP90AA1 (0.40) MAPTKDM4EALKBH5FTOMEN1
SCHEMBL24078219 0.74 HSP90AA1 (0.40) MAPTKDM4EALKBH5FTOMEN1
SCHEMBL22178595 0.73 CHEK1 (0.39) MAPTKDM4EALKBH5FTOMCL1
SCHEMBL19011053 0.73 KDM4E (0.42) MAPTKDM4EBRD4ALKBH5FTO
SCHEMBL15460131 0.73 ALKBH5 (0.43) MAPTKDM4EBRD4ALKBH5FTO
SCHEMBL23772993 0.71 ALKBH5 (0.43) MAPTKDM4EBRD4ALKBH5FTO
SCHEMBL22178472 0.70 MAPT (0.49) MAPTKDM4EBRD4ALKBH5FTO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, LAGE3, NQO1 MAPT 4078/4885KDM4E 1533/4885BRD4 193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.